摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(3-amino-2,3-dideoxy-β-D-arabino-hexopyranosyl)uracil | 80646-96-4

中文名称
——
中文别名
——
英文名称
1-(3-amino-2,3-dideoxy-β-D-arabino-hexopyranosyl)uracil
英文别名
1-(3-amino-2,3-dideoxy-β-D-arabinohexopyranosyl)uracil;1-(3-amino-2,3-dideoxy-beta-D-glucopyranosyl)uracil;1-[(2R,4R,5S,6R)-4-amino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]pyrimidine-2,4-dione
1-(3-amino-2,3-dideoxy-β-D-arabino-hexopyranosyl)uracil化学式
CAS
80646-96-4
化学式
C10H15N3O5
mdl
——
分子量
257.246
InChiKey
HJJUSGVWHJXMIU-GCXDCGAKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.5
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    125
  • 氢给体数:
    4
  • 氢受体数:
    6

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    乙酸酐1-(3-amino-2,3-dideoxy-β-D-arabino-hexopyranosyl)uracil吡啶 为溶剂, 反应 4.5h, 以98%的产率得到1-(3-acetamido-4,6-di-O-acetyl-2,3-dideoxy-β-D-arabinohexopyranosyl)uracil
    参考文献:
    名称:
    Polydeoxyaminohexopyranosylnucleosides. Synthesis of 1-(2,3,4-Trideoxy-3-nitro-β-D-erythro- andthreo-hexopyranosyl)-uracils from Uridine
    摘要:
    The first synthesis of nitro-multideoxy-sugar containing nucleosides was achieved. 1-(4,6-O-Benzyiidene-3-deoxy-3-nitro-beta-D-glucopyranosyl)uracil (3) was converted in 75% yield into 1-(4,6-O-benzylidene-2,3-dideoxy-3-nitro-arabinohexopyranosyl)uracil (7) by acetylation followed by NaBH4 reduction in methanol. De-O-benzylidenation with CF3CO2H afforded crystalline 1-(2,3-dideoxy-3-nitro-beta-D-arabinohexopyranosyl)uracil (8) was obtained in 87% yield. Raney Ni reduction of 8 afforded the corresponding 3'-amino-nucleoside 9. Acetylation of 8 followed by NaBH4 treatment afforded an 8.1 mixture from which 1-(2,3,4-trideoxy-3-nitro-beta-D-threohexopyranosyl)-uracil (14) was obtained in pure crystalline form. After Raney Ni reduction of the mixture, 1-(3-amino-2,3,4-trideoxy-beta-D-threohexopyranosyl)uracil (16) and its erythro epimer 21 were isolated. 1-(4,6-O-Benzylidene-2, 3 dideoxy-3-nitro-beta-D-lyxohexopyranosyl)uracil (24) was prepared in 72% yield from 1-(4,6-O-benzylidene-3 -deoxy-3-nitro-beta-D-galactopyranosyl)uracil (4) by acetylation and subsequent reduction with NaBH4. De-O-benzylid-enation of 23 afforded 1-(2,3,4-trideoxy-3-nitro-beta-D-lyxohexopyranosyl)uracil (25) in 83% yield. Schmidt-Rutz reaction of 25 followed by NaBH4 reduction afforded a mixture of three and erythro isomers of 2',3',4'-trideoxy-3'-nitrohexopyranosyluracil, from which pure 16 and 21 were obtained.
    DOI:
    10.1080/07328319608002380
  • 作为产物:
    描述:
    1-(4,6-O-benzylidene-3-deoxy-3-nitro-β-D-glucopyranosyl)uracil 在 吡啶tin 、 sodium tetrahydroborate 、 乙酸酐溶剂黄146 作用下, 以 甲醇 为溶剂, 反应 9.67h, 生成 1-(3-amino-2,3-dideoxy-β-D-arabino-hexopyranosyl)uracil
    参考文献:
    名称:
    Stereoselective Reactions OF 1-(4,6-O-Benzylidene-2,3-Didehydro-2,3-dideoxy-3-nitro-β-D-hexopyranosyl)uracil with some Nucleophiles¶
    摘要:
    Michael addition of benzylamine, piperidine, morpholine, pyrrolidine, cyclohexylamine, allylamine and dimethylmalonate to the nitroolefin (5) generated in situ from 1-(4,6-O-benzylidene-3-deoxy-3-nitro-beta-D-glucopyranosyl)uracil (4b) gave the corresponding 2-(substituted-amino)-3-deoxy-3-nitro-beta-D-glucopyranosides (6a-f and 6h). Reaction of 4b with N,N'-carbonyldiimidazole directly gave 6g. Compound 4b was converted into the 2-deoxy analogue (8), which was reduced to the 3-amino (9) and 3-hydroxylamino analogue (10).
    DOI:
    10.1080/07328319608002131
点击查看最新优质反应信息

文献信息

  • L-nucleoside analogues and pharmaceutical compositions
    申请人:Medivir AB
    公开号:US05747473A1
    公开(公告)日:1998-05-05
    ##STR1## Novel antiviral compounds of formulae (1A) and (1B), wherein X and R.sub.1 -R.sub.4 are as stated in claim 1 in the form of an .alpha.- or .beta.-anomer or a mixture thereof, and pharmaceutically acceptable salts thereof, are disclosed, as well as a new method for preparation thereof. Said compounds can be used for treatment of infections caused by viruses requiring reverse transcriptase for replication, such as HIV and hepatitis B virus.
    本发明公开了式(1A)和(1B)的新型抗病毒化合物,其中X和R.sub.1-R.sub.4如权利要求书中所述,以α-或β-异构体或其混合物的形式存在,并且其药物可接受的盐,以及其制备的新方法。所述化合物可用于治疗由需要反转录酶复制的病毒引起的感染,例如HIV和乙型肝炎病毒。
  • US5473063A
    申请人:——
    公开号:US5473063A
    公开(公告)日:1995-12-05
  • US5747473A
    申请人:——
    公开号:US5747473A
    公开(公告)日:1998-05-05
  • US5952500A
    申请人:——
    公开号:US5952500A
    公开(公告)日:1999-09-14
  • US6121431A
    申请人:——
    公开号:US6121431A
    公开(公告)日:2000-09-19
查看更多